Hemoglobin A1c (HbA1c) is widely used for diabetes monitoring and diagnosis. As HbA1c results play a key role in clinical decision-making, analytical accuracy is essential to ensure appropriate patient management.
Hemoglobin variants can interfere with HbA1c measurements obtained with some assay methods. Common variants such as Hb S, Hb C, Hb E and Hb D-Punjab may lead to falsely elevated or falsely decreased HbA1c results. Clinically significant interference can result in inappropriate treatment decisions, including over-treatment with an increased risk of hypoglycemia or under-treatment associated with prolonged hyperglycemia and diabetes-related complications. In addition, inaccurate HbA1c results may impact the diagnosis of diabetes.
Hemoglobin variants are not uncommon and may be encountered in routine laboratory practice, particularly in regions with ethnically diverse populations. It is therefore important for laboratories to understand the susceptibility of HbA1c methods to variant interference and to select methods that have been demonstrated to provide accurate results in the presence of common hemoglobin variants. In this study, several methods, including capillary electrophoresis (CE) systems, showed no clinically significant interference from Hb S, Hb C, Hb E or Hb D-Punjab traits.
Test associated with this resource
Related instruments
コンパクトかつ導入しやすい全自動キャピラリー電気泳動システム
進化が違いを生む
Sebiaの専門知識を結集した高スループット装置。
Discover more resources on Diabetes
このセクションには広く一般に公開されることを目的とした情報が含まれており、そのため、お住まいの国では入手できない、または有効でない製品の詳細や情報が含まれている可能性があります。お近くのSebia担当者にお問い合わせください。医療従事者向けの情報です。試薬の添付文書および機器の取扱説明書の指示を注意深くお読みください。